CONTROVERSIES IN THE TREATMENT OF DUCTAL CARCINOMA IN SITU
- 1 April 1996
- journal article
- review article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 76 (2) , 243-265
- https://doi.org/10.1016/s0039-6109(05)70437-0
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Ductal carcinoma in situ of the male breastCancer, 1994
- Noninvasive ductal carcinoma of the breast: The relevance of histologic categorizationHuman Pathology, 1993
- Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancerHuman Pathology, 1992
- Microvessel quantitation and prognosis in invasive breast carcinomaHuman Pathology, 1992
- Results of treating ductal carcinomaIn situ of the breast with conservative surgery and radiation therapyCancer, 1991
- Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situHuman Pathology, 1990
- Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breastThe American Journal of Surgery, 1990
- Follow-up of two treatment modalities for ductal cancer in situ of the breastBritish Journal of Surgery, 1989
- Management of screen detected ductal carcinoma in situ of the female breastBritish Journal of Surgery, 1989
- CARCINOMA IN SITU CONTRASTED WITH BENIGN PENETRATING EPITHELIUMJAMA, 1932